MOR — Morphosys AG Balance Sheet
0.000.00%
- €2.55bn
- €2.31bn
- €238.28m
Annual balance sheet for Morphosys AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 273 | 1,090 | 994 | 907 | 683 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 20.3 | 89.8 | 85.8 | 112 | 42.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 304 | 1,207 | 1,133 | 1,089 | 814 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 47.8 | 50.7 | 49.6 | 51 | 15 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 496 | 1,660 | 2,556 | 2,397 | 2,026 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 61.6 | 200 | 285 | 278 | 264 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 102 | 1,038 | 2,311 | 2,240 | 1,977 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 395 | 621 | 245 | 157 | 49 |
| Total Liabilities & Shareholders' Equity | 496 | 1,660 | 2,556 | 2,397 | 2,026 |
| Total Common Shares Outstanding |